Israel Englander’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Buy
3,030,287
+970,828
+47% +$5.86M 0.01% 1921
2026
Q1
$12.7M Sell
2,059,459
-69,579
-3% -$578K 0.01% 1948
2025
Q4
$22.2M Sell
2,129,038
-64,024
-3% -$642K 0.01% 1479
2025
Q3
$19.7M Buy
2,193,062
+1,241,885
+131% +$10.9M 0.01% 1681
2025
Q2
$12.4M Buy
951,177
+53,331
+6% +$802K 0.01% 2043
2025
Q1
$22.7M Sell
897,846
-109,693
-11% -$3.26M 0.01% 1394
2024
Q4
$34.6M Buy
1,007,539
+440,071
+78% +$19.8M 0.02% 1056
2024
Q3
$28M Buy
567,468
+378,882
+201% +$19.4M 0.01% 1248
2024
Q2
$11.3M Sell
188,586
-166,168
-47% -$9.5M 0.01% 1977
2024
Q1
$18.3M Buy
354,754
+32,150
+10% +$1.58M 0.01% 1632
2023
Q4
$13M Sell
322,604
-838,449
-72% -$24.6M 0.01% 1938
2023
Q3
$32.4M Sell
1,161,053
-72,300
-6% -$2.16M 0.02% 1036
2023
Q2
$35.5M Buy
1,233,353
+550,082
+81% +$12.2M 0.02% 965
2023
Q1
$11.4M Buy
683,271
+288,300
+73% +$4.07M 0.01% 1826
2022
Q4
$5M Sell
394,971
-90,723
-19% -$1.1M ﹤0.01% 2809
2022
Q3
$5.83M Sell
485,694
-23,774
-5% -$326K ﹤0.01% 2746
2022
Q2
$7.17M Sell
509,468
-434,812
-46% -$5.73M ﹤0.01% 2417
2022
Q1
$11.7M Buy
944,280
+723,329
+327% +$8.68M 0.01% 1968
2021
Q4
$2.49M Sell
220,951
-108,597
-33% -$1.31M ﹤0.01% 3565
2021
Q3
$4.17M Buy
+329,548
New +$4.54M ﹤0.01% 3077

Other funds holding RXST

Israel Englander's RXST Position: Q2 2026 in Review

Israel Englander increased its RxSight (RXST) stake by 47% in Q2 2026, buying an estimated $5.86M and bringing the position to 3,030,287 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #1921.

Israel Englander first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $35.5M in Q2 2023. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Israel Englander held 3,030,287 shares of RxSight worth $14.6M as of Q2 2026.
  • Israel Englander bought 970,828 RxSight shares in Q2 2026, an estimated $5.86M.
  • RxSight made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1921 holding.
  • Israel Englander first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Israel Englander's RxSight position peaked at $35.5M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.